Acute Kidney Injury in Patients with Acute Type B Aortic Dissection.


Journal

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
ISSN: 1532-2165
Titre abrégé: Eur J Vasc Endovasc Surg
Pays: England
ID NLM: 9512728

Informations de publication

Date de publication:
02 2023
Historique:
received: 12 03 2022
revised: 22 08 2022
accepted: 15 10 2022
pubmed: 24 10 2022
medline: 15 2 2023
entrez: 23 10 2022
Statut: ppublish

Résumé

Acute kidney injury (AKI) is common in patients with aortic diseases; however, it has not been extensively studied in acute type B aortic dissection (TBAD). AKI is known to be associated with adverse kidney outcomes and premature death. This study investigated the incidence and impact of AKI in patients with acute TBAD. This was a retrospective study including data from two tertiary vascular centres in the UK. Case notes and electronic records were reviewed for consecutive patients presenting with acute symptomatic TBAD. Patients were managed according to a uniform clinical protocol; both patients who underwent surgery and those managed conservatively were included in this analysis. Serum creatinine values were used to calculate the number of patients who developed AKI, based on validated Kidney Disease Improving Global Outcomes definitions. Associations between incidence of AKI, death, and Major Adverse Kidney Events (MAKE; defined as death, dialysis and/or drop in estimated glomerular filtration rate > 25%) were explored. Overall, 66 (42.6%) of 155 patients developed AKI within one week of presenting with TBAD. Of these, 23 patients (34.8%) had stage 1, 26 patients (39.4%) stage 2, and 17 patients (25.8%) stage 3 AKI. MAKE at 30 and 90 days occurred in 17 (11.0%) and 12 patients (7.7%), respectively. AKI was associated with significantly worse outcomes, with a 24.2% mortality rate in the AKI group compared with 7.8% among those with no AKI (p <.001); this association was also significant in adjusted analyses, both in patients who did and did not undergo surgery. AKI is very common among patients presenting with acute TBAD, even in clinically uncomplicated disease. There was a significant association with mortality and MAKE, whether patients underwent surgery or not. This warrants further investigation to better understand the underlying causes of the AKI and investigate management strategies which may improve outcomes.

Identifiants

pubmed: 36273677
pii: S1078-5884(22)00685-2
doi: 10.1016/j.ejvs.2022.10.032
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

256-262

Subventions

Organisme : British Heart Foundation
ID : FS/17/24/32596
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Crown Copyright © 2022. Published by Elsevier B.V. All rights reserved.

Auteurs

Mustafa Musajee (M)

Department of Vascular Surgery, Guy's and St Thomas' NHS Trust, London, UK.

Emmanuel Katsogridakis (E)

Department of Cardiovascular Sciences, University of Leicester, UK; Leicester Vascular Institute, Glenfield Hospital, Leicester, UK.

Yusuf Kiberu (Y)

Department of Vascular Surgery, Guy's and St Thomas' NHS Trust, London, UK.

Christopher Banerjee (C)

Department of Vascular Surgery, Guy's and St Thomas' NHS Trust, London, UK.

Rhys George (R)

Department of Vascular Surgery, Guy's and St Thomas' NHS Trust, London, UK.

Bijan Modarai (B)

Department of Vascular Surgery, Guy's and St Thomas' NHS Trust, London, UK; School of cardiovascular medicine and sciences, King's College London, UK.

Athanasios Saratzis (A)

Department of Cardiovascular Sciences, University of Leicester, UK; Leicester Vascular Institute, Glenfield Hospital, Leicester, UK.

Becky Sandford (B)

Department of Vascular Surgery, Guy's and St Thomas' NHS Trust, London, UK. Electronic address: becky.sandford@gstt.nhs.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH